APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Coated Coronary Balloon Catheter

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug Coated Coronary Balloon Catheter Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025195 pages

Choose your research edition.

Industry ResearchDrug Coated Coronary Balloon Catheter Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Coated Coronary Balloon Catheter Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Drug Coated Coronary Balloon Catheter Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Coated Coronary Balloon Catheter Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Coated Coronary Balloon Catheter Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Drug Coated Coronary Balloon Catheter market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drug Coated Coronary Balloon Catheter is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Coated Coronary Balloon Catheter is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Coated Coronary Balloon Catheter is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug Coated Coronary Balloon Catheter is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Coated Coronary Balloon Catheter include B.Braun, BD, Biotronik, Bonston Scientific, Concept Medical Inc, Eurocor Tech GmbH, Medronic, USM Healthcare and Zhejiang Barty Medical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drug Coated Coronary Balloon Catheter market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Coated Coronary Balloon Catheter and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Coated Coronary Balloon Catheter sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drug Coated Coronary Balloon Catheter market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Coated Coronary Balloon Catheter Segment by Company

B.Braun

BD

Biotronik

Bonston Scientific

Concept Medical Inc

Eurocor Tech GmbH

Medronic

USM Healthcare

Zhejiang Barty Medical Technology

Blue Sail Medical

Lepu Medical Technology

Yinyi (Liaoning) Biotech

MicroPort

Acotec Scientific

GrandPharma(Cardionovum)

Drug Coated Coronary Balloon Catheter Segment by Type

Sirolimus

Beautiful Moss

Paclitaxel

Others

Drug Coated Coronary Balloon Catheter Segment by Application

Hospital

Clinic

Others

Drug Coated Coronary Balloon Catheter Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Coated Coronary Balloon Catheter market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Coated Coronary Balloon Catheter and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Coated Coronary Balloon Catheter.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drug Coated Coronary Balloon Catheter market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug Coated Coronary Balloon Catheter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drug Coated Coronary Balloon Catheter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drug Coated Coronary Balloon Catheter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drug Coated Coronary Balloon Catheter Industry Trends Table 2. Drug Coated Coronary Balloon Catheter Industry Drivers Table 3. Drug Coated Coronary Balloon Catheter Industry Opportunities and Challenges Table 4. Drug Coated Coronary Balloon Catheter Industry Restraints Table 5. Global Drug Coated Coronary Balloon Catheter Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drug Coated Coronary Balloon Catheter Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Manufacturers Table 9. Global Drug Coated Coronary Balloon Catheter Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Drug Coated Coronary Balloon Catheter Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drug Coated Coronary Balloon Catheter Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drug Coated Coronary Balloon Catheter Manufacturers, Product Type & Application Table 13. Global Drug Coated Coronary Balloon Catheter Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drug Coated Coronary Balloon Catheter by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Sirolimus Table 17. Major Manufacturers of Beautiful Moss Table 18. Major Manufacturers of Paclitaxel Table 19. Major Manufacturers of Others Table 20. Global Drug Coated Coronary Balloon Catheter Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Drug Coated Coronary Balloon Catheter Sales by Type (2021-2026) & (K Units) Table 22. Global Drug Coated Coronary Balloon Catheter Sales by Type (2027-2032) & (K Units) Table 23. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2021-2026) Table 24. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2027-2032) Table 25. Global Drug Coated Coronary Balloon Catheter Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Drug Coated Coronary Balloon Catheter Revenue by Type (2021-2026) & (K Units) Table 27. Global Drug Coated Coronary Balloon Catheter Revenue by Type (2027-2032) & (K Units) Table 28. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2021-2026) Table 29. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Others Table 33. Global Drug Coated Coronary Balloon Catheter Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Drug Coated Coronary Balloon Catheter Sales by Application (2021-2026) & (K Units) Table 35. Global Drug Coated Coronary Balloon Catheter Sales by Application (2027-2032) & (K Units) Table 36. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2021-2026) Table 37. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2027-2032) Table 38. Global Drug Coated Coronary Balloon Catheter Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Drug Coated Coronary Balloon Catheter Revenue by Application (2021-2026) & (K Units) Table 40. Global Drug Coated Coronary Balloon Catheter Revenue by Application (2027-2032) & (K Units) Table 41. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2021-2026) Table 42. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2027-2032) Table 43. Global Drug Coated Coronary Balloon Catheter Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Drug Coated Coronary Balloon Catheter Sales by Region (2021-2026) & (K Units) Table 45. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Region (2021-2026) Table 46. Global Drug Coated Coronary Balloon Catheter Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Drug Coated Coronary Balloon Catheter Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Drug Coated Coronary Balloon Catheter Sales by Country (2021-2026) & (K Units) Table 50. North America Drug Coated Coronary Balloon Catheter Sales by Country (2027-2032) & (K Units) Table 51. Europe Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Drug Coated Coronary Balloon Catheter Sales by Country (2021-2026) & (K Units) Table 53. Europe Drug Coated Coronary Balloon Catheter Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2027-2032) & (K Units) Table 60. Global Drug Coated Coronary Balloon Catheter Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Drug Coated Coronary Balloon Catheter Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Drug Coated Coronary Balloon Catheter Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Region (2021-2026) Table 64. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Region (2027-2032) Table 65. B.Braun Company Information Table 66. B.Braun Business Overview Table 67. B.Braun Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. B.Braun Drug Coated Coronary Balloon Catheter Product Portfolio Table 69. B.Braun Recent Development Table 70. BD Company Information Table 71. BD Business Overview Table 72. BD Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. BD Drug Coated Coronary Balloon Catheter Product Portfolio Table 74. BD Recent Development Table 75. Biotronik Company Information Table 76. Biotronik Business Overview Table 77. Biotronik Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Biotronik Drug Coated Coronary Balloon Catheter Product Portfolio Table 79. Biotronik Recent Development Table 80. Bonston Scientific Company Information Table 81. Bonston Scientific Business Overview Table 82. Bonston Scientific Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bonston Scientific Drug Coated Coronary Balloon Catheter Product Portfolio Table 84. Bonston Scientific Recent Development Table 85. Concept Medical Inc Company Information Table 86. Concept Medical Inc Business Overview Table 87. Concept Medical Inc Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Concept Medical Inc Drug Coated Coronary Balloon Catheter Product Portfolio Table 89. Concept Medical Inc Recent Development Table 90. Eurocor Tech GmbH Company Information Table 91. Eurocor Tech GmbH Business Overview Table 92. Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Product Portfolio Table 94. Eurocor Tech GmbH Recent Development Table 95. Medronic Company Information Table 96. Medronic Business Overview Table 97. Medronic Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Medronic Drug Coated Coronary Balloon Catheter Product Portfolio Table 99. Medronic Recent Development Table 100. USM Healthcare Company Information Table 101. USM Healthcare Business Overview Table 102. USM Healthcare Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. USM Healthcare Drug Coated Coronary Balloon Catheter Product Portfolio Table 104. USM Healthcare Recent Development Table 105. Zhejiang Barty Medical Technology Company Information Table 106. Zhejiang Barty Medical Technology Business Overview Table 107. Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio Table 109. Zhejiang Barty Medical Technology Recent Development Table 110. Blue Sail Medical Company Information Table 111. Blue Sail Medical Business Overview Table 112. Blue Sail Medical Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Blue Sail Medical Drug Coated Coronary Balloon Catheter Product Portfolio Table 114. Blue Sail Medical Recent Development Table 115. Lepu Medical Technology Company Information Table 116. Lepu Medical Technology Business Overview Table 117. Lepu Medical Technology Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Lepu Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio Table 119. Lepu Medical Technology Recent Development Table 120. Yinyi (Liaoning) Biotech Company Information Table 121. Yinyi (Liaoning) Biotech Business Overview Table 122. Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Product Portfolio Table 124. Yinyi (Liaoning) Biotech Recent Development Table 125. MicroPort Company Information Table 126. MicroPort Business Overview Table 127. MicroPort Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. MicroPort Drug Coated Coronary Balloon Catheter Product Portfolio Table 129. MicroPort Recent Development Table 130. Acotec Scientific Company Information Table 131. Acotec Scientific Business Overview Table 132. Acotec Scientific Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Acotec Scientific Drug Coated Coronary Balloon Catheter Product Portfolio Table 134. Acotec Scientific Recent Development Table 135. GrandPharma(Cardionovum) Company Information Table 136. GrandPharma(Cardionovum) Business Overview Table 137. GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Product Portfolio Table 139. GrandPharma(Cardionovum) Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Drug Coated Coronary Balloon Catheter Distributors List Table 143. Drug Coated Coronary Balloon Catheter Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Drug Coated Coronary Balloon Catheter Product Image Figure 2. Global Drug Coated Coronary Balloon Catheter Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Coated Coronary Balloon Catheter Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Coated Coronary Balloon Catheter Sales (2021-2032) & (K Units) Figure 5. Global Drug Coated Coronary Balloon Catheter Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drug Coated Coronary Balloon Catheter Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Sirolimus Image Figure 9. Beautiful Moss Image Figure 10. Paclitaxel Image Figure 11. Others Image Figure 12. Global Drug Coated Coronary Balloon Catheter Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Drug Coated Coronary Balloon Catheter Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2021-2032) Figure 15. Global Drug Coated Coronary Balloon Catheter Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Drug Coated Coronary Balloon Catheter Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Drug Coated Coronary Balloon Catheter Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Drug Coated Coronary Balloon Catheter Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2021-2032) Figure 24. Global Drug Coated Coronary Balloon Catheter Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Drug Coated Coronary Balloon Catheter Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2021-2032) Figure 27. North America Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2021-2032) Figure 29. U.S. Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2021-2032) Figure 34. Germany Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2021-2032) Figure 41. China Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2021-2032) Figure 49. Brazil Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Drug Coated Coronary Balloon Catheter Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Drug Coated Coronary Balloon Catheter Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Drug Coated Coronary Balloon Catheter Revenue (2021-2032) & (US$ Million) Figure 60. North America Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Drug Coated Coronary Balloon Catheter Revenue (2021-2032) & (US$ Million) Figure 62. Europe Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Drug Coated Coronary Balloon Catheter Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Drug Coated Coronary Balloon Catheter Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Drug Coated Coronary Balloon Catheter Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Sirolimus
  • Beautiful Moss
  • Paclitaxel
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • B.Braun
  • BD
  • Biotronik
  • Bonston Scientific
  • Concept Medical Inc
  • Eurocor Tech GmbH
  • Medronic
  • USM Healthcare
  • Zhejiang Barty Medical Technology
  • Blue Sail Medical
  • Lepu Medical Technology
  • Yinyi (Liaoning) Biotech
  • MicroPort
  • Acotec Scientific
  • GrandPharma(Cardionovum)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Coated Coronary Balloon Catheter Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Coated Coronary Balloon Catheter Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drug Coated Coronary Balloon Catheter Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drug Coated Coronary Balloon Catheter Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drug Coated Coronary Balloon Catheter Market Dynamics
  1. 2.1 Drug Coated Coronary Balloon Catheter Industry Trends
  2. 2.2 Drug Coated Coronary Balloon Catheter Industry Drivers
  3. 2.3 Drug Coated Coronary Balloon Catheter Industry Opportunities and Challenges
  4. 2.4 Drug Coated Coronary Balloon Catheter Industry Restraints
3 Drug Coated Coronary Balloon Catheter Market by Manufacturers
  1. 3.1 Global Drug Coated Coronary Balloon Catheter Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drug Coated Coronary Balloon Catheter Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drug Coated Coronary Balloon Catheter Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drug Coated Coronary Balloon Catheter Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug Coated Coronary Balloon Catheter Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drug Coated Coronary Balloon Catheter Manufacturers, Product Type & Application
  7. 3.7 Global Drug Coated Coronary Balloon Catheter Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug Coated Coronary Balloon Catheter Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug Coated Coronary Balloon Catheter Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug Coated Coronary Balloon Catheter Tier 1, Tier 2, and Tier 3
4 Drug Coated Coronary Balloon Catheter Market by Type
  1. 4.1 Drug Coated Coronary Balloon Catheter Type Introduction
  2. 4.1.1 Sirolimus
  3. 4.1.2 Beautiful Moss
  4. 4.1.3 Paclitaxel
  5. 4.1.4 Others
  6. 4.2 Global Drug Coated Coronary Balloon Catheter Sales by Type
  7. 4.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Drug Coated Coronary Balloon Catheter Sales by Type (2021-2032)
  9. 4.2.3 Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2021-2032)
  10. 4.3 Global Drug Coated Coronary Balloon Catheter Revenue by Type
  11. 4.3.1 Global Drug Coated Coronary Balloon Catheter Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Drug Coated Coronary Balloon Catheter Revenue by Type (2021-2032)
  13. 4.3.3 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2021-2032)
5 Drug Coated Coronary Balloon Catheter Market by Application
  1. 5.1 Drug Coated Coronary Balloon Catheter Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Drug Coated Coronary Balloon Catheter Sales by Application
  6. 5.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug Coated Coronary Balloon Catheter Sales by Application (2021-2032)
  8. 5.2.3 Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2021-2032)
  9. 5.3 Global Drug Coated Coronary Balloon Catheter Revenue by Application
  10. 5.3.1 Global Drug Coated Coronary Balloon Catheter Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Drug Coated Coronary Balloon Catheter Revenue by Application (2021-2032)
  12. 5.3.3 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2021-2032)
6 Global Drug Coated Coronary Balloon Catheter Sales by Region
  1. 6.1 Global Drug Coated Coronary Balloon Catheter Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Coated Coronary Balloon Catheter Sales by Region (2021-2032)
  3. 6.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Region (2021-2026)
  4. 6.2.2 Global Drug Coated Coronary Balloon Catheter Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drug Coated Coronary Balloon Catheter Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drug Coated Coronary Balloon Catheter Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drug Coated Coronary Balloon Catheter Revenue by Region
  1. 7.1 Global Drug Coated Coronary Balloon Catheter Revenue by Region
  2. 7.1.1 Global Drug Coated Coronary Balloon Catheter Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drug Coated Coronary Balloon Catheter Revenue by Region (2021-2026)
  4. 7.1.3 Global Drug Coated Coronary Balloon Catheter Revenue by Region (2027-2032)
  5. 7.1.4 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drug Coated Coronary Balloon Catheter Revenue (2021-2032)
  8. 7.2.2 North America Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drug Coated Coronary Balloon Catheter Revenue (2021-2032)
  11. 7.3.2 Europe Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drug Coated Coronary Balloon Catheter Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 B.Braun
  2. 8.1.1 B.Braun Company Information
  3. 8.1.2 B.Braun Business Overview
  4. 8.1.3 B.Braun Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 B.Braun Drug Coated Coronary Balloon Catheter Product Portfolio
  6. 8.1.5 B.Braun Recent Developments
  7. 8.2 BD
  8. 8.2.1 BD Company Information
  9. 8.2.2 BD Business Overview
  10. 8.2.3 BD Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BD Drug Coated Coronary Balloon Catheter Product Portfolio
  12. 8.2.5 BD Recent Developments
  13. 8.3 Biotronik
  14. 8.3.1 Biotronik Company Information
  15. 8.3.2 Biotronik Business Overview
  16. 8.3.3 Biotronik Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biotronik Drug Coated Coronary Balloon Catheter Product Portfolio
  18. 8.3.5 Biotronik Recent Developments
  19. 8.4 Bonston Scientific
  20. 8.4.1 Bonston Scientific Company Information
  21. 8.4.2 Bonston Scientific Business Overview
  22. 8.4.3 Bonston Scientific Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bonston Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
  24. 8.4.5 Bonston Scientific Recent Developments
  25. 8.5 Concept Medical Inc
  26. 8.5.1 Concept Medical Inc Company Information
  27. 8.5.2 Concept Medical Inc Business Overview
  28. 8.5.3 Concept Medical Inc Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Concept Medical Inc Drug Coated Coronary Balloon Catheter Product Portfolio
  30. 8.5.5 Concept Medical Inc Recent Developments
  31. 8.6 Eurocor Tech GmbH
  32. 8.6.1 Eurocor Tech GmbH Company Information
  33. 8.6.2 Eurocor Tech GmbH Business Overview
  34. 8.6.3 Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Product Portfolio
  36. 8.6.5 Eurocor Tech GmbH Recent Developments
  37. 8.7 Medronic
  38. 8.7.1 Medronic Company Information
  39. 8.7.2 Medronic Business Overview
  40. 8.7.3 Medronic Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Medronic Drug Coated Coronary Balloon Catheter Product Portfolio
  42. 8.7.5 Medronic Recent Developments
  43. 8.8 USM Healthcare
  44. 8.8.1 USM Healthcare Company Information
  45. 8.8.2 USM Healthcare Business Overview
  46. 8.8.3 USM Healthcare Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 USM Healthcare Drug Coated Coronary Balloon Catheter Product Portfolio
  48. 8.8.5 USM Healthcare Recent Developments
  49. 8.9 Zhejiang Barty Medical Technology
  50. 8.9.1 Zhejiang Barty Medical Technology Company Information
  51. 8.9.2 Zhejiang Barty Medical Technology Business Overview
  52. 8.9.3 Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
  54. 8.9.5 Zhejiang Barty Medical Technology Recent Developments
  55. 8.10 Blue Sail Medical
  56. 8.10.1 Blue Sail Medical Company Information
  57. 8.10.2 Blue Sail Medical Business Overview
  58. 8.10.3 Blue Sail Medical Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Blue Sail Medical Drug Coated Coronary Balloon Catheter Product Portfolio
  60. 8.10.5 Blue Sail Medical Recent Developments
  61. 8.11 Lepu Medical Technology
  62. 8.11.1 Lepu Medical Technology Company Information
  63. 8.11.2 Lepu Medical Technology Business Overview
  64. 8.11.3 Lepu Medical Technology Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lepu Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
  66. 8.11.5 Lepu Medical Technology Recent Developments
  67. 8.12 Yinyi (Liaoning) Biotech
  68. 8.12.1 Yinyi (Liaoning) Biotech Company Information
  69. 8.12.2 Yinyi (Liaoning) Biotech Business Overview
  70. 8.12.3 Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Product Portfolio
  72. 8.12.5 Yinyi (Liaoning) Biotech Recent Developments
  73. 8.13 MicroPort
  74. 8.13.1 MicroPort Company Information
  75. 8.13.2 MicroPort Business Overview
  76. 8.13.3 MicroPort Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MicroPort Drug Coated Coronary Balloon Catheter Product Portfolio
  78. 8.13.5 MicroPort Recent Developments
  79. 8.14 Acotec Scientific
  80. 8.14.1 Acotec Scientific Company Information
  81. 8.14.2 Acotec Scientific Business Overview
  82. 8.14.3 Acotec Scientific Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Acotec Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
  84. 8.14.5 Acotec Scientific Recent Developments
  85. 8.15 GrandPharma(Cardionovum)
  86. 8.15.1 GrandPharma(Cardionovum) Company Information
  87. 8.15.2 GrandPharma(Cardionovum) Business Overview
  88. 8.15.3 GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Product Portfolio
  90. 8.15.5 GrandPharma(Cardionovum) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drug Coated Coronary Balloon Catheter Value Chain Analysis
  2. 9.1.1 Drug Coated Coronary Balloon Catheter Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drug Coated Coronary Balloon Catheter Production Mode & Process
  6. 9.2 Drug Coated Coronary Balloon Catheter Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drug Coated Coronary Balloon Catheter Distributors
  9. 9.2.3 Drug Coated Coronary Balloon Catheter Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst